ADEWALE BUSARI: Open Payments
NPI 1942861950 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 11 payments from 4 companies in 2025. Trend: 2023 $14 · 2024 $116 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $128 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, COBENFY, ABILIFY ASIMTUFII, Qelbree.
Industry payments across NV — which companies pay providers there.
